[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100442185":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":40,"centralContacts":44,"locations":51,"responsibleParty":69,"collaborators":49,"id":71,"slug":72,"hasResults":73,"nctId":74,"briefTitle":75,"officialTitle":76,"acronym":49,"eligibilityCriteria":77,"healthyVolunteers":73,"sex":78,"minAge":79,"maxAge":49,"enrollmentInfo":80,"targetDuration":49,"studyType":83,"phases":84,"briefSummary":86,"conditions":87,"keywords":49,"overallStatus":89,"whyStopped":49,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},{"fullName":5,"class":6},"M.D. Anderson Cancer Center","OTHER",[8,16],{"label":9,"type":10,"description":11,"interventionNames":12},"Cohort I (preoperative injection)","EXPERIMENTAL","Patients receive FerroTrace peritumorally within days 1-21. Patients then undergo gastrectomy and receive ICG peritumorally.",[13,14,15],"Procedure: Gastrectomy","Drug: Indocyanine Green","Other: Iron Conjugated Polymers in Saline Suspension",{"label":17,"type":10,"description":18,"interventionNames":19},"Cohort II (intraoperative)","Patients undergo gastrectomy and receive FerroTrace and ICG peritumorally during surgery.",[13,14,15],[21,28,35],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"PROCEDURE","Gastrectomy","Undergo surgery",[9,17],[27],"Gastric Resection",{"type":29,"name":30,"description":31,"armGroupLabels":32,"otherNames":33},"DRUG","Indocyanine Green","Given peritumorally",[9,17],[34],"ICG",{"type":6,"name":36,"description":31,"armGroupLabels":37,"otherNames":38},"Iron Conjugated Polymers in Saline Suspension",[9,17],[39],"FerroTrace",[41],{"name":42,"affiliation":5,"role":43},"Naruhiko Ikoma","PRINCIPAL_INVESTIGATOR",[45],{"name":46,"role":47,"phone":48,"phoneExt":49,"email":50},"Naruhiko Ikoma, MD","CONTACT","832-729-2675",null,"nikoma@mdanderson.org",[52],{"facility":53,"status":49,"city":54,"state":55,"zip":56,"country":57,"countryCode":58,"cosmosGeoPoint":59,"geoPoint":64,"contacts":65},"M D Anderson Cancer Center","Houston","Texas","77030","United States","US",{"type":60,"coordinates":61},"Point",[62,63],-95.36327,29.76328,{"lat":63,"lon":62},[66,68],{"name":42,"role":47,"phone":67,"phoneExt":49,"email":50},"713-792-6940",{"name":42,"role":43,"phone":49,"phoneExt":49,"email":49},{"type":70,"investigatorFullName":49,"investigatorTitle":49,"investigatorAffiliation":49,"oldNameTitle":49,"oldOrganization":49},"SPONSOR","100442185","phase-1-magnetic-sentinel-lymph-node-mapping-in-gastric-cancer-100442185",false,"NCT05038098","Magnetic Sentinel Lymph Node Mapping in Gastric Cancer","Magnetic Sentinel Lymph Node Mapping in Gastric Cancer, Safety and Feasibility Clinical Trial","Inclusion Criteria:\n\n* Age 18 or older\n* Willing to provide informed consent\n* Biopsy proven gastric cancer, undergoing curative-intent gastrectomy\n* No distant metastases\n* Pathologic diagnosis of gastric adenocarcinoma\n* Pre-treatment endoscopic measurement of less than or equal to 4 cm in diameter of the gastric cancer\n\nExclusion Criteria:\n\n* Contraindications to surgery +\u002F- adjuvant therapy\n* Allergy or intolerance to iron oxide compounds\n* Allergy or intolerance to iodides\n* Iron overload disorder\n* Pregnant or lactating women\\*\n\n  * Use of contraception is required for females during the study. Male patients who are sexually active with a female of childbearing potential are allowed for study enrollment and will not require use of contraception","ALL","18 Years",{"count":81,"type":82},20,"ESTIMATED","INTERVENTIONAL",[85],"PHASE1","This phase I finds out the possible benefits and\u002For side effects of using magnetic tracer FerroTrace and the fluorescent dye indocyanine green to identify the lymph nodes that cancer is most likely to have spread to in patients with gastric cancer that are undergoing gastrectomy. Using FerroTrace in combination with the indocyanine green dye may help researchers better detect the disease.",[88],"Gastric Adenocarcinoma","NOT_YET_RECRUITING","2026-08-13",{"date":92,"type":93},"2026-08-14","ACTUAL",{"date":95,"type":82},"2026-12-31",{"date":97,"type":82},"2027-02-02",{"name":5,"class":6},1]